tion of therapy of 10.8Â months, with a 75% success rate 
in bone and joint TB [26].
According to the current guidelines, a therapy dura-
tion of 9 months is recommended for bone and joint 
tuberculosis: fourfold therapy with isoniazid (INH), 
rifampicin (RMP), pyrazinamide (PZA), and ethambu-
tol (EMB) over 2 months and then twofold therapy with 
INH, RMP over 7 months [11].
Thus, in our case, we observed a steady decrease of 
synovial changes in the follow-up MRI controls and a 
good clinical outcome based on the collected scores. 
Surgical treatment should be evaluated carefully and 
only be used as a last resort or when antibiotic therapy